310 related articles for article (PubMed ID: 33598509)
1. Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche.
Yasuda T; Ishimoto T; Baba H
Regen Ther; 2021 Jun; 17():8-12. PubMed ID: 33598509
[TBL] [Abstract][Full Text] [Related]
2. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology underlying the robustness of cancer stem cells.
Yoshida GJ; Saya H
Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in drug delivery systems for targeting cancer stem cells.
Duan H; Liu Y; Gao Z; Huang W
Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
[TBL] [Abstract][Full Text] [Related]
6. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.
Ghashghaeinia M; Köberle M; Mrowietz U; Bernhardt I
Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective.
Han J; Won M; Kim JH; Jung E; Min K; Jangili P; Kim JS
Chem Soc Rev; 2020 Nov; 49(22):7856-7878. PubMed ID: 32633291
[TBL] [Abstract][Full Text] [Related]
8. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.
Pastò A; Bellio C; Pilotto G; Ciminale V; Silic-Benussi M; Guzzo G; Rasola A; Frasson C; Nardo G; Zulato E; Nicoletto MO; Manicone M; Indraccolo S; Amadori A
Oncotarget; 2014 Jun; 5(12):4305-19. PubMed ID: 24946808
[TBL] [Abstract][Full Text] [Related]
10. The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity.
Walsh HR; Cruickshank BM; Brown JM; Marcato P
Front Oncol; 2019; 9():753. PubMed ID: 31552162
[TBL] [Abstract][Full Text] [Related]
11. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
12. Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma.
Nishino M; Ozaki M; Hegab AE; Hamamoto J; Kagawa S; Arai D; Yasuda H; Naoki K; Soejima K; Saya H; Betsuyaku T
J Cancer; 2017; 8(10):1774-1785. PubMed ID: 28819374
[No Abstract] [Full Text] [Related]
13. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
Front Oncol; 2018; 8():203. PubMed ID: 29922594
[TBL] [Abstract][Full Text] [Related]
14. Targeting redox regulation and autophagy systems in cancer stem cells.
Khan SU; Rayees S; Sharma P; Malik F
Clin Exp Med; 2023 Sep; 23(5):1405-1423. PubMed ID: 36473988
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.
Gao Z; Zhang C; Peng F; Chen Q; Zhao Y; Chen L; Wang X; Chen X
Stem Cell Res Ther; 2022 May; 13(1):191. PubMed ID: 35526054
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
17. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells.
Bi Z; Zhang Q; Fu Y; Wadgaonkar P; Zhang W; Almutairy B; Xu L; Rice M; Qiu Y; Thakur C; Chen F
Theranostics; 2020; 10(9):4134-4149. PubMed ID: 32226544
[TBL] [Abstract][Full Text] [Related]
20. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
